In addition, in HER2-positive breast cancer, Endophilin A2 (encoded by SH3GL1) has been shown to increase HER2 internalization and enhance the sensitivity of breast cancer cells to trastuzumab-based therapy. Here, SH3GL1 is linked to breast cancer.